Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety
Authors
Keywords
-
Journal
BLOOD
Volume 118, Issue 6, Pages 1495-1503
Publisher
American Society of Hematology
Online
2011-06-15
DOI
10.1182/blood-2011-02-337089
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Allo-HLA reactivity of virus-specific memory T cells is common
- (2010) A. L. Amir et al. BLOOD
- Peptide Vaccination after T-Cell Transfer Causes Massive Clonal Expansion, Tumor Eradication, and Manageable Cytokine Storm
- (2010) L. V. Ly et al. CANCER RESEARCH
- Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy
- (2010) Gavin M Bendle et al. NATURE MEDICINE
- Mixed T cell receptor dimers harbor potentially harmful neoreactivity
- (2010) M. M. van Loenen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lack of specific -retroviral vector long terminal repeat promoter silencing in patients receiving genetically engineered lymphocytes and activation upon lymphocyte restimulation
- (2009) W. R. Burns et al. BLOOD
- A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS
- (2009) U. Keilholz et al. BLOOD
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
- (2009) L. A. Johnson et al. BLOOD
- Improved Expression and Reactivity of Transduced Tumor-Specific TCRs in Human Lymphocytes by Specific Silencing of Endogenous TCR
- (2009) S. Okamoto et al. CANCER RESEARCH
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
- (2009) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Adoptive cell therapy for the treatment of patients with metastatic melanoma
- (2009) Steven A Rosenberg et al. CURRENT OPINION IN IMMUNOLOGY
- Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID mice
- (2009) S.-A. Xue et al. HAEMATOLOGICA
- Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by StandardizedWT1Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study
- (2009) Daniela Cilloni et al. JOURNAL OF CLINICAL ONCOLOGY
- HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes
- (2009) K. Suemori et al. JOURNAL OF GENERAL VIROLOGY
- Aurora-A kinase: a novel target of cellular immunotherapy for leukemia
- (2008) T. Ochi et al. BLOOD
- WT1 peptide vaccine for the treatment of cancer
- (2008) Yoshihiro Oka et al. CURRENT OPINION IN IMMUNOLOGY
- Long-term phenotypic, functional and genetic stability of cancer-specific T-cell receptor (TCR) αβ genes transduced to CD8+ T cells
- (2008) A Hiasa et al. GENE THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More